GlobalData on MSN17h
NovoCure scoops FDA approval on wearable for metastatic cancer treatment
Optune Lua received FDA approval based on data from the pivotal LUNAR trial which demonstrated significant median OS ...
MassDevice15h
Novocure wins FDA nod for lung cancer treatment wearable
Novocure announced on Tuesday that the FDA treated its Optune Lua wearable device for treating metastatic non-small cell lung ...
Morgan Stanley and Cisco Shine, S&P 500 Eyes Rebound in Today’s Trading
S&P 500 and Nasdaq 100 futures steady amid tech losses. Morgan Stanley beats Q3 estimates, up 3%, and Cisco climbs 2% on AI ...
Frontiers28m
Early Phase Clinical Trials for the Development of Novel Immunotherapeutic Anti-cancer Agents
Drug development in oncology is historically challenging, exhibiting a very high attrition rate, with low rates of approval for novel treatments when compared to other therapeutic areas. At present, ...
Investor's Business Daily on MSN11h
Intuitive Surgical Adds To 41% Run With Massive Profit Beat, Strong Procedure Growth
Intuitive Surgical stock surged late Thursday after the robotic surgery giant blasted third-quarter earnings expectations out of the water.